Seeing Is Believing
Currently out of the existing stock ratings of Matt Miksic, 201 are a BUY (82.04%), 32 are a HOLD (13.06%), 12 are a SELL (4.9%).
Analyst Matt Miksic works at BARCLAYS with a stock forecast success ratio of 53.79% fulfilled within 244.14 days on average.
Matt Miksic’s has documented 520 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 25-Apr-2024.
Analyst best performing recommendations are on ISRG (INTUITIVE SURGICAL).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 10/17/2022. The price target of $235 was fulfilled within 8 days with a profit of $44.88 (23.61%) receiving and performance score of 29.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
140
$32.47 (30.20%)
141
9 days ago
13/22 (59.09%)
$32.93 (30.76%)
291
Buy
125
$17.47 (16.25%)
114
27 days ago
4/5 (80%)
$14.89 (13.52%)
388
Buy
126
$18.47 (17.18%)
130
3 months 6 days ago
7/14 (50%)
$13.55 (12.05%)
292
Buy
127
$19.47 (18.11%)
110
3 months 6 days ago
12/18 (66.67%)
$14.55 (12.94%)
190
Buy
125
$17.47 (16.25%)
125
3 months 7 days ago
6/7 (85.71%)
$14.23 (12.85%)
250
Which stock is Matt Miksic is most bullish on?
Which stock is Matt Miksic is most reserved on?
What Year was the first public recommendation made by Matt Miksic?